Skip to main content
Premium Trial:

Request an Annual Quote

Greece Joins Europe's ELIXIR Bioinformatics Project

Premium

The European Bioinformatics Institute said this week that Greece has agreed to participate in the European Life-science Infrastructure for Biological Information, or ELIXIR, project.

According to the EBI, Greece has signed the ELIXIR memorandum of understanding, which formally commits signatories to support the development of the bioinformatics infrastructure.

Signing the MOU also gives Greece a delegate on the ELIXIR Interim Board, which is the main body negotiating the final legal and governance structure of the pan-European project.

Other existing ELIXIR contributors include Portugal, Italy, the Czech Republic, Denmark, Estonia, Finland, Israel, Italy, the Netherlands, Norway, Slovenia, Spain, Sweden, Switzerland, the UK, and the European Molecular Biology Laboratory (BI 11/30/2012).

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.